Company History

  • November 2014

    Shandong Taibang received the approval from the Hebei Provincial Health and Family Planning Commission to build two new plasma collection stations in Hebei Province.
  • October 2014

    Shandong Taibang received manufacturing approval certificate for Human Prothrombin Complex Concentrate ("PCC") from China Food and Drug Administration (“CFDA”).
  • Sept 2014

    China Biologic increased its equity interests in Guizhou Taibang to 76.23% through purchasing additional interest from a minority shareholder.
  • June-July 2014

    China Biologic sold 920,000 shares of common stock from its treasury stock in a follow-on offering, and raised net proceeds of approximately $33.2 million.
FirstPage | PreviousPage | NextPage | LastPage CurrentPageIndex:1 [1] [2] [3] [4] [5] [6] [7] 
© 2014 China Biologic Products, Inc. All Rights Reserved.